Valdecoxib Patent Expiration

Valdecoxib is Used for managing symptoms of osteoarthritis, adult rheumatoid arthritis, and primary dysmenorrhea. It was first introduced by Gd Searle Llc in its drug Bextra on Nov 16, 2001.


Valdecoxib Patents

Given below is the list of patents protecting Valdecoxib, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Bextra US5633272 Substituted isoxazoles for the treatment of inflammation Feb 13, 2015

(Expired)

Gd Searle



Valdecoxib's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List